Inactive Instrument

Other languages Oxygen Biotherapeutics Inc Nasdaq

Equities

US69207P3082

End-of-day quote Nasdaq Other stock markets
- ^USD	-

05-14	Tenax Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Tenax Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14
Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28
Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28
Tenax Therapeutics Secures Global Rights for Levosimendan	02-20
Tenax Therapeutics, Inc. and Orion Corporation Enters into an Amendment to Certain License Agreement	02-20
Top Midday Decliners	02-08
Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected	02-08
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday as Investors Await Economic Data	02-08
US Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade Data	02-08
Tenax Therapeutics Enrolls First Patient in Phase 3 Level Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in PH-HFpEF Patients	02-08
Sector Update: Health Care Stocks Gain Late Afternoon	02-06
Sector Update: Health Care	02-06
Top Midday Gainers	02-06
Tenax Therapeutics, Inc. Appoints Lawrence R. Hoffman as Principal Financial Officer and Principal Accounting Officer	01-12
Tenax Therapeutics to Implement 1-for-80 Reverse Stock Split	12-29
Tenax Therapeutics, Inc. Appoints Javed Butler to its PH-HFpEF Scientific Advisory Board	11-17
Tenax Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
Sector Update: Health Care Stocks Gain in Late Afternoon Trading	11-13
Sector Update: Health Care	11-13
Top Midday Gainers	11-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Oxygen Biotherapeutics Inc Nasdaq

Equities

US69207P3082

Other languages

Filters